Clinical Trials in North Carolina

Showing 11241-11260 of 20,428 trials

Essure (Model ESS310) Placement Rate Study

NCT02064413

To evaluate the safety and successful placement rate of Essure Model ESS310 device and any factors that may influence the successful placement rate of this device.

Contraception

Bayer134 participantsStarted Mar 2014

Glendale, Arizona, United States • Phoenix, Arizona, United States • Colorado Springs, Colorado, United States +13 more locations

COMPLETEDNA41 miles

Rheos System for the Treatment of HFpEF Heart Failure

NCT00957073

The purpose of this clinical investigation (NCT00957073) is to continue long-term follow-up of device arm subjects enrolled in the HOPE4HF Trial, utilizing the BAROSTIM NEO™ LEGACY device for Implantable Pulse Generator (IPG) replacements.

Heart Failure

CVRx, Inc.19 participantsStarted Aug 2009

Mobile, Alabama, United States • Inglewood, California, United States • Los Angeles, California, United States +19 more locations

Essure (Model ESS310) Placement Rate Study

Rheos System for the Treatment of HFpEF Heart Failure

Find Trials by Condition in North Carolina

ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer

Severe Asthma Research Program - Wake Forest University

OCT Pilot in Esophagus

Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy in Infants

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease

Peer Led Asthma Self Management for Adolescents: PLASMA

Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes

Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors